Proteomics in Multiple Sclerosis: The Perspective of the Clinician

Multiple sclerosis (MS) is the inflammatory demyelinating and neurodegenerative disease of the central nervous system (CNS) that affects approximately 2.8 million people worldwide. In the last decade, a new era was heralded in by a new phenotypic classification, a new diagnostic protocol and the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandi, Dániel, Kokas, Zsófia, Biernacki, Tamás, Bencsik, Krisztina, Klivényi, Péter, Vécsei, László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100097/
https://www.ncbi.nlm.nih.gov/pubmed/35563559
http://dx.doi.org/10.3390/ijms23095162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100097/
https://www.ncbi.nlm.nih.gov/pubmed/35563559
http://dx.doi.org/10.3390/ijms23095162

Ejemplares similares